Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Barrett

Showing results (301-310 of 318) with videos related to

Pageof 32
Sort By:
Viruses|February 28, 2023
Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against OmicronLinhui Hao, Tien-Ying Hsiang, Ronit R Dalmat, et al.
Plos Neglected Tropical Diseases|July 30, 2025
Anti-Cryptosporidium efficacy of BKI-1708, an inhibitor of Cryptosporidium calcium-dependent protein kinase 1Ryan Choi, Matthew A Hulverson, Deborah A Schaefer, et al.
ACS Infectious Diseases|October 11, 2023
Shotgun Kinetic Target-Guided Synthesis Approach Enables the Discovery of Small-Molecule Inhibitors against Pathogenic Free-Living Amoeba GlucokinasesMintesinot Kassu, Prakash T Parvatkar, Jillian Milanes, et al.
Protein Science : a Publication of the Protein Society|January 14, 2020
Structures of glyceraldehyde 3-phosphate dehydrogenase in Neisseria gonorrhoeae and Chlamydia trachomatisKayleigh F Barrett, David M Dranow, Isabelle Q Phan, et al.
Antimicrobial Agents and Chemotherapy|March 15, 2023
Comparison of Toxicities among Different Bumped Kinase Inhibitor Analogs for Treatment of CryptosporidiosisMatthew A Hulverson, Ryan Choi, Deborah A Schaefer, et al.
ACS Infectious Diseases|November 1, 2016
Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetaseStephen Nakazawa Hewitt, David M Dranow, Benjamin G Horst, et al.
Journal of Medicinal Chemistry|June 17, 2016
Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of ToxoplasmosisRama Subba Rao Vidadala, Kasey L Rivas, Kayode K Ojo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2020
Clofazimine for Treatment of Cryptosporidiosis in Human Immunodeficiency Virus Infected Adults: An Experimental Medicine, Randomized, Double-blind, Placebo-controlled Phase 2a TrialPy Iroh Tam, S L M Arnold, L K Barrett, et al.
ACS Medicinal Chemistry Letters|December 23, 2015
SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of <i>Toxoplasma gondii</i> CDPK1Wenlin Huang, Kayode K Ojo, Zhongsheng Zhang, et al.
Veterinary Parasitology|January 8, 2021
One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseasesWesley C Van Voorhis, Matthew A Hulverson, Ryan Choi, et al.
Pageof 32

Showing results (301-310 of 318) with videos related to

Sort By:
Pageof 32
Viruses|February 28, 2023
Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against OmicronLinhui Hao, Tien-Ying Hsiang, Ronit R Dalmat, et al.
Plos Neglected Tropical Diseases|July 30, 2025
Anti-Cryptosporidium efficacy of BKI-1708, an inhibitor of Cryptosporidium calcium-dependent protein kinase 1Ryan Choi, Matthew A Hulverson, Deborah A Schaefer, et al.
ACS Infectious Diseases|October 11, 2023
Shotgun Kinetic Target-Guided Synthesis Approach Enables the Discovery of Small-Molecule Inhibitors against Pathogenic Free-Living Amoeba GlucokinasesMintesinot Kassu, Prakash T Parvatkar, Jillian Milanes, et al.
Protein Science : a Publication of the Protein Society|January 14, 2020
Structures of glyceraldehyde 3-phosphate dehydrogenase in Neisseria gonorrhoeae and Chlamydia trachomatisKayleigh F Barrett, David M Dranow, Isabelle Q Phan, et al.
Antimicrobial Agents and Chemotherapy|March 15, 2023
Comparison of Toxicities among Different Bumped Kinase Inhibitor Analogs for Treatment of CryptosporidiosisMatthew A Hulverson, Ryan Choi, Deborah A Schaefer, et al.
ACS Infectious Diseases|November 1, 2016
Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetaseStephen Nakazawa Hewitt, David M Dranow, Benjamin G Horst, et al.
Journal of Medicinal Chemistry|June 17, 2016
Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of ToxoplasmosisRama Subba Rao Vidadala, Kasey L Rivas, Kayode K Ojo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2020
Clofazimine for Treatment of Cryptosporidiosis in Human Immunodeficiency Virus Infected Adults: An Experimental Medicine, Randomized, Double-blind, Placebo-controlled Phase 2a TrialPy Iroh Tam, S L M Arnold, L K Barrett, et al.
ACS Medicinal Chemistry Letters|December 23, 2015
SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of <i>Toxoplasma gondii</i> CDPK1Wenlin Huang, Kayode K Ojo, Zhongsheng Zhang, et al.
Veterinary Parasitology|January 8, 2021
One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseasesWesley C Van Voorhis, Matthew A Hulverson, Ryan Choi, et al.
Pageof 32